Covidien launches vessel sealers; Applied Proteomics eyes Dx for colon, pancreatic cancer;

@FierceMedDev: ICYMI: Med tech's hottest takeover targets for the rest of 2013. Special report | Follow @FierceMedDev

> Covidien ($COV) has launched two vessel sealers under its LigaSure line, designed for laparoscopic surgeries. News

> Applied Proteomics has inked a collaboration deal with the German Cancer Research Center to develop blood tests for colon and pancreatic cancer. Release

> Olympus ($OCPNY) is rolling out its 510(k) cleared curvilinear ultrasound gastrovideoscope, which it said is the only forward-viewing product of its kind. Item

> France's EyeBrain has launched a device designed to determine cerebral function by tracking head and eye movements. More

> Tyber Medical gained an FDA 510(k) clearance for its TyPeek and Peek interbody implant systems. Item

> Zimmer's ($ZMH) spine division will distribute Frontier Medical Devices' implant designed to treat degenerative disc disease and instability, known as the Lateral Locking Cage. Item

Biotech News

@FierceBiotech: Popular from FierceCRO - Analyst: Bet on another boom for big CROs. Story | Follow @FierceBiotech

@JohnCFierce: ICYMI: 10 top drugs in biopharma's late-stage pipeline. Special report | Follow @JohnCFierce

@DamianFierce: Time to find out whether device firms are allowed at the biotech IPO party: LDR prices a $75M debut. News | Follow @DamianFierce

@EmilyMFierce: Altered antimicrobials could combat drug-resistant bacteria. ICYMI from FierceBiotech Research | Follow @EmilyMFierce

> Ariad hammered on toxicity concerns for leukemia drug Iclusig. News

> Bayer wins key FDA approval for lung disease drug Adempas. More

> Shutdown nixes Merck's FDA panel date, spares other drugs. Story

Pharma News

@FiercePharma: Tops this AM on our website: Novartis eyes sell-offs, with decision on individual units expected soon. More | Follow @FiercePharma

@EricPFierce: Ranbaxy shopping for FDA approved plant. Article | Get all FiercePharmaManufacturing headlines via email | Follow @EricPFierce

@CarlyHFierce: GSK has always said it would be difficult to copy its respiratory drug Advair--and Teva agrees. Article | Follow @CarlyHFierce

> Former Lilly scientists indicted for passing R&D secrets to Chinese drugmaker. More

> Drugmakers want to block Maine from cheaper Canadian drugs. News

> Who'd like Tom Hanks to be their diabetes role model? Story

Drug Delivery News

@MichaelGFierce: Stem cell 'drug factories' target, treat inflammation. More | Follow @MichaelGFierce

> U.S.-based scientists win Nobel Prize for cell transport exploration. Item

> Study: Disc-shaped nanoparticles best at crossing cell membranes. More

> Cook touts positive data for Zilver paclitaxel-eluting stent after April recall. Story

> Alnylam posts positive PhI for RNAi cholesterol drug. Report

Diagnostics News

@MarkHFierce: Sign up for your free, weekly dose of FierceDiagnostics. Sign up here | Follow @MarkHFierce

> Roche looks to the future with two new molecular Dx systems. Article

> Exact Sciences denies talks underway to invest in Israeli cancer Dx startup. Story

> Boreal Genomics pulls in $18M Series C for genomic research and Dx test expansion. Report

> Renishaw Diagnostics seals deal with tech transfer group to develop infectious disease tests. More

Suggested Articles

J&J launched a virtual clinical study to gauge whether Apple’s iPhone and ECG-enabled smartwatch can help reduce the risk of stroke and catch AFib.

The Salt Lake City-based developer said its Logix Smart test is now available to be exported from Utah to countries requiring the CE Mark.

Dexcom received a new European approval for its wearable continuous glucose monitor in pregnant women across Type 1, Type 2 and gestational diabetes.